Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 0.75 | 2.26 |
NAV | ₹24.55 | ₹168.01 |
Fund Started | 02 Mar 2019 | 13 Oct 2005 |
Fund Size | ₹222.61 Cr | ₹1374.33 Cr |
Exit Load | Exit load of 0.5% if redeemed within 15 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 1.77% | 5.10% |
3 Year | 13.52% | 20.15% |
5 Year | 17.68% | 24.39% |
1 Year
3 Year
5 Year
Equity | 99.99% | 95.01% |
Cash | 0.01% | 4.99% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Hindustan Unilever Ltd. | 8.87% |
Nestle India Ltd. | 7.86% |
Sun Pharmaceutical Industries Ltd. | 7.30% |
Apollo Hospitals Enterprise Ltd. | 6.53% |
ITC Ltd. | 6.22% |
Tata Consultancy Services Ltd. | 4.12% |
Tata Consumer Products Ltd. | 3.99% |
Cipla Ltd. | 3.63% |
ICICI Bank Ltd. | 3.36% |
Bharti Airtel Ltd. | 2.94% |
Name | Assets |
|---|---|
Infosys Ltd. | 8.83% |
ICICI Bank Ltd. | 6.77% |
Reliance Industries Ltd. | 6.47% |
HDFC Bank Ltd. | 5.24% |
NTPC Ltd. | 4.83% |
Bharti Airtel Ltd. | 4.81% |
Larsen & Toubro Ltd. | 4.31% |
Sun Pharmaceutical Industries Ltd. | 3.59% |
Dr. Reddy's Laboratories Ltd. | 3.04% |
Tata Consultancy Services Ltd. | 2.94% |
Name | Raviprakash Sharma | Sri Sharma |
Start Date | 22 Aug 2011 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to provide long term capital appreciation by investing in a diversified basket of companies in Nifty 50 Index while aiming for minimizing the portfolio volatility. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 02 Mar 2019 | 13 Oct 2005 |
Description
Launch Date